Arronax Nantes > Pre-clinical experimentation and clinical research > Our publications > 2022 > Communication 2022 4
Communication 2022 4
Locoregional Astatine-211 Radioimmunotherapy Targeting Syndecan-1 in a Syngeneic Glioblastoma Mouse Model
Roncali L, Roy C, Marionneau-Lambot S, Gouard S, Eychenne R, Avril S, Guérard F, Hindré F, Chérel M, Garcion E
15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, october 5-8 2022